Logo image of USAR

USA RARE EARTH INC (USAR) Stock Fundamental Analysis

NASDAQ:USAR - Nasdaq - US91733P1075 - Common Stock - Currency: USD

10.31  +0.65 (+6.73%)

After market: 10.29 -0.02 (-0.19%)

Fundamental Rating

2

Taking everything into account, USAR scores 2 out of 10 in our fundamental rating. USAR was compared to 154 industry peers in the Metals & Mining industry. USAR may be in some trouble as it scores bad on both profitability and health. USAR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

USAR had positive earnings in the past year.
In the past year USAR has reported a negative cash flow from operations.
USAR Yearly Net Income VS EBIT VS OCF VS FCFUSAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

Looking at the Return On Assets, with a value of 32.73%, USAR belongs to the top of the industry, outperforming 97.39% of the companies in the same industry.
With an excellent Return On Equity value of 112.13%, USAR belongs to the best of the industry, outperforming 99.35% of the companies in the same industry.
Industry RankSector Rank
ROA 32.73%
ROE 112.13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USAR Yearly ROA, ROE, ROICUSAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 40 60 80 100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for USAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USAR Yearly Profit, Operating, Gross MarginsUSAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for USAR has been reduced compared to 1 year ago.
Compared to 1 year ago, USAR has a worse debt to assets ratio.
USAR Yearly Shares OutstandingUSAR Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M
USAR Yearly Total Debt VS Total AssetsUSAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

USAR has an Altman-Z score of 26.05. This indicates that USAR is financially healthy and has little risk of bankruptcy at the moment.
USAR has a Altman-Z score of 26.05. This is amongst the best in the industry. USAR outperforms 87.58% of its industry peers.
USAR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
USAR has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: USAR outperforms 53.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 26.05
ROIC/WACCN/A
WACCN/A
USAR Yearly LT Debt VS Equity VS FCFUSAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.02 indicates that USAR may have some problems paying its short term obligations.
The Current ratio of USAR (0.02) is worse than 95.42% of its industry peers.
USAR has a Quick Ratio of 0.02. This is a bad value and indicates that USAR is not financially healthy enough and could expect problems in meeting its short term obligations.
USAR has a worse Quick ratio (0.02) than 95.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
USAR Yearly Current Assets VS Current LiabilitesUSAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

USAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.85%, which is quite impressive.
EPS 1Y (TTM)36.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, USAR will show a very negative growth in Earnings Per Share. The EPS will decrease by -46.53% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-122.93%
EPS Next 2Y-46.73%
EPS Next 3Y-46.53%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USAR Yearly Revenue VS EstimatesUSAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 50M 100M 150M
USAR Yearly EPS VS EstimatesUSAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 35.55, the valuation of USAR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of USAR indicates a somewhat cheap valuation: USAR is cheaper than 62.75% of the companies listed in the same industry.
USAR is valuated rather expensively when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for USAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 35.55
Fwd PE N/A
USAR Price Earnings VS Forward Price EarningsUSAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAR Per share dataUSAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

USAR's earnings are expected to decrease with -46.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.73%
EPS Next 3Y-46.53%

More info and screens

0

5. Dividend

5.1 Amount

USAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

USA RARE EARTH INC

NASDAQ:USAR (5/2/2025, 8:27:08 PM)

After market: 10.29 -0.02 (-0.19%)

10.31

+0.65 (+6.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)05-14 2025-05-14
Inst Owners25.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change1.74%
Market Cap844.90M
Analysts82.86
Price Target15.3 (48.4%)
Short Float %1.85%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.55
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 119.94
P/tB 119.94
EV/EBITDA N/A
EPS(TTM)0.29
EY2.81%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 32.73%
ROE 112.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 26.05
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.08%
EPS Next Y-122.93%
EPS Next 2Y-46.73%
EPS Next 3Y-46.53%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-312.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.53%
OCF growth 3YN/A
OCF growth 5YN/A